Literature DB >> 7719142

Malignant hyperthermia in a patient with Becker muscular dystrophy: dystrophin analysis and caffeine contracture study.

N Ohkoshi1, T Yoshizawa, H Mizusawa, S Shoji, M Toyama, K Iida, Y Sugishita, K Hamano, A Takagi, K Goto.   

Abstract

We present a 17-year-old boy with Becker muscular dystrophy (BMD) who developed hyperthermia and heart failure after general anesthesia. He presented clinical features of malignant hyperthermia (MH), and had masseter spasm and elevated body temperature (38.7 degrees C) with very high serum CK activity (107,000 IUl-1). Dystrophin tests confirmed a clinical diagnosis of BMD in the patient, i.e. faint and patchy immunostaining pattern of skeletal muscle, truncated dystrophin protein and a deletion of exons 3 and 4 of the dystrophin gene. To inquire into the mechanism of MH associated in the patient, we tested caffeine contracture reaction by the skinned fiber method. We found an increased sensitivity to caffeine only in type 1 muscle fibers. The rate of Ca(2+)-induced Ca2+ release (CICR) was normal, suggesting that the mechanism of "MH" observed in our patient with BMD is not the same as that of classical MH. A possible mechanism might be related to derangements of the sarcoplasmic reticulum membrane in BMD, which sensitize the membrane to caffeine or other agents.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7719142     DOI: 10.1016/0960-8966(94)e0026-5

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  3 in total

1.  Repeated total intravenous anesthesia for a patient with a history of enflurane-induced rhabdomyolysis.

Authors:  Akiko Suzuki; Eiji Hashiba; Akinori Matsui; Takeshi Kubota; Hironori Ishihara; Akitomo Matsuki
Journal:  J Anesth       Date:  1997-09       Impact factor: 2.078

Review 2.  Investigation of muscle disease.

Authors:  F L Mastaglia; N G Laing
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-03       Impact factor: 10.154

Review 3.  Cardiac involvement in Becker muscular dystrophy.

Authors:  Josef Finsterer; Claudia Stöllberger
Journal:  Can J Cardiol       Date:  2008-10       Impact factor: 5.223

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.